ES2156862T3 - METHOD FOR SELECTING MORPHOGENIC PROTEINS. - Google Patents
METHOD FOR SELECTING MORPHOGENIC PROTEINS.Info
- Publication number
- ES2156862T3 ES2156862T3 ES92921799T ES92921799T ES2156862T3 ES 2156862 T3 ES2156862 T3 ES 2156862T3 ES 92921799 T ES92921799 T ES 92921799T ES 92921799 T ES92921799 T ES 92921799T ES 2156862 T3 ES2156862 T3 ES 2156862T3
- Authority
- ES
- Spain
- Prior art keywords
- gene
- expression
- epithelial cells
- compound
- level
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a method of identifying a tissue source of epithelial cells that express a cellular gene encoding a polypeptide, the amino acid sequence of which comprises (I) a sequence having at least 70% amino acid sequence homology with the C-terminal seven-cysteine domain of human OP-1, residues 38-139 of SEQ ID No. 5, or (II) a sequence defined by generic sequence 6, SEQ ID No. 31, said polypeptide, when dimerized with a second said polypeptide, forming a protein having the property of inducing a developmental cascade of tissue-specific morphogenesis in a mammal, said method further being a method of screening a candidate compound for the ability to modulate expression of said gene, said method comprising the steps of: (a) incubating at least two preparations comprising epithelial cells derived from at least two different tissues of an organism with a compound shown to modulate expression of said gene for a time sufficient to allow said compound to affect the expression of said gene; (b) assaying said at least two preparations of cells for the presence or amount of an expression product of said gene, wherein a change in the level of said expression product relative to the level thereof in said at least two preparations of cells in the absence of said compound identifies cells wherein a change occurred as a tissue source of epithelial cells suitable for screening a candidate compound for the ability to modulate expression of said gene; (c) incubating said candidate compound with epithelial cells cultured from the tissue source for which a change in the level of gene expression was observed in step (b), for a time sufficient to allow said candidate compound to affect the expression of said gene; and (d) assaying said cultured epithelial cells for the presence or amount of an expression product of said gene, wherein a change in the level of said expression product relative to the level thereof in said cultured epithelial cells in the absence of said candidate compound is indicative of the ability of said compound to modulate expression of said gene in said cultured epithelial cells.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75286191A | 1991-08-30 | 1991-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2156862T3 true ES2156862T3 (en) | 2001-08-01 |
Family
ID=25028180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92921799T Expired - Lifetime ES2156862T3 (en) | 1991-08-30 | 1992-08-28 | METHOD FOR SELECTING MORPHOGENIC PROTEINS. |
Country Status (8)
Country | Link |
---|---|
EP (3) | EP1033574A3 (en) |
JP (3) | JP3616089B2 (en) |
AT (1) | ATE197611T1 (en) |
AU (1) | AU678345B2 (en) |
CA (1) | CA2116560C (en) |
DE (1) | DE69231567T2 (en) |
ES (1) | ES2156862T3 (en) |
WO (1) | WO1993005172A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071695A (en) * | 1992-02-21 | 2000-06-06 | Creative Biomolecules, Inc. | Methods and products for identification of modulators of osteogenic protein-1 gene expression |
WO1995014104A1 (en) * | 1993-11-16 | 1995-05-26 | Children's Medical Center Corporation | Method of identifying a substance capable of inducing bone formation |
US5863738A (en) * | 1994-04-29 | 1999-01-26 | Creative Biomolecules, Inc. | Methods of antagonizing OP-1 binding to a cell surface receptor utilizing ALK polypeptides |
AU703445B2 (en) * | 1994-06-07 | 1999-03-25 | Stryker Corporation | Methods and compositions for modulating morphogenic protein expression |
US20030167492A1 (en) * | 1994-07-08 | 2003-09-04 | Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a gdf-11 dominant negative polypeptide, and methods of making and using same |
US6103491A (en) * | 1995-07-26 | 2000-08-15 | Creative Biomolecules, Inc. | Methods and compositions for identifying morphogen analogs |
US7306903B1 (en) | 1995-07-26 | 2007-12-11 | Curis, Inc. | Methods and compositions for identifying morphogen analogs |
US6090544A (en) * | 1995-07-26 | 2000-07-18 | Creative Biomolecules, Inc. | Methods and compositions for identifying morphogen analogs |
EP0845006A2 (en) * | 1995-08-14 | 1998-06-03 | Creative Biomolecules, Inc. | Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
ATE493141T1 (en) | 1996-03-22 | 2011-01-15 | Stryker Corp | METHOD FOR IMPROVED FUNCTIONAL RECOVERY OF MOTOR COORDINATION, LANGUAGE OR SENSORY PERCEPTION AFTER CNS TRAUMA OR ISCHEMIA |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
US5928940A (en) * | 1996-09-24 | 1999-07-27 | Creative Biomolecules, Inc. | Morphogen-responsive signal transducer and methods of use thereof |
DE69826854T2 (en) | 1997-05-05 | 2006-02-02 | Curis, Inc., Cambridge | THERAPIES FOR THE TREATMENT OF ACUTE KIDNEY FAILURES |
CA2291514C (en) * | 1997-05-30 | 2011-07-12 | Creative Biomolecules, Inc. | Methods for evaluating tissue morphogenesis and activity |
US7147839B2 (en) | 1998-05-29 | 2006-12-12 | Curis, Inc. | Methods for evaluating tissue morphogenesis and activity |
US6524797B1 (en) | 1999-05-10 | 2003-02-25 | Bernhard O. Palsson | Methods of identifying therapeutic compounds in a genetically defined setting |
WO2009102966A2 (en) | 2008-02-13 | 2009-08-20 | Keith Hruska | Method of treating vascular sclerosis |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980281A (en) * | 1988-02-10 | 1990-12-25 | Housey Gerard M | Method of screening for protein inhibitors and activators |
WO1990000619A1 (en) * | 1988-07-08 | 1990-01-25 | University College London | Analysis of cell modifying substances |
DK0429570T3 (en) * | 1989-03-28 | 1998-04-27 | Genetics Inst | Osteoinducing preparations |
AU632160B2 (en) * | 1989-08-21 | 1992-12-17 | Celtrix Pharmaceuticals, Inc. | Bone-specific protein |
DK0575555T3 (en) * | 1991-03-11 | 2001-11-05 | Curis Inc | Protein-induced morphogenesis |
-
1992
- 1992-08-28 CA CA002116560A patent/CA2116560C/en not_active Expired - Fee Related
- 1992-08-28 ES ES92921799T patent/ES2156862T3/en not_active Expired - Lifetime
- 1992-08-28 AU AU28624/92A patent/AU678345B2/en not_active Ceased
- 1992-08-28 EP EP00100232A patent/EP1033574A3/en not_active Withdrawn
- 1992-08-28 JP JP50534593A patent/JP3616089B2/en not_active Expired - Fee Related
- 1992-08-28 EP EP92921799A patent/EP0601129B1/en not_active Expired - Lifetime
- 1992-08-28 EP EP97202681A patent/EP0825442A3/en not_active Ceased
- 1992-08-28 WO PCT/US1992/007359 patent/WO1993005172A1/en active IP Right Grant
- 1992-08-28 AT AT92921799T patent/ATE197611T1/en not_active IP Right Cessation
- 1992-08-28 DE DE69231567T patent/DE69231567T2/en not_active Expired - Fee Related
-
2003
- 2003-01-23 JP JP2003014941A patent/JP2004069670A/en active Pending
-
2004
- 2004-03-24 JP JP2004087203A patent/JP2004267211A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2116560A1 (en) | 1993-03-18 |
WO1993005172A1 (en) | 1993-03-18 |
AU678345B2 (en) | 1997-05-29 |
EP0825442A2 (en) | 1998-02-25 |
EP0601129B1 (en) | 2000-11-15 |
ATE197611T1 (en) | 2000-12-15 |
CA2116560C (en) | 2002-01-08 |
EP1033574A2 (en) | 2000-09-06 |
DE69231567T2 (en) | 2001-06-28 |
AU2862492A (en) | 1993-04-05 |
JP3616089B2 (en) | 2005-02-02 |
DE69231567D1 (en) | 2000-12-21 |
EP1033574A3 (en) | 2004-01-28 |
JPH06510432A (en) | 1994-11-24 |
EP0601129A1 (en) | 1994-06-15 |
EP0825442A3 (en) | 2004-02-11 |
JP2004267211A (en) | 2004-09-30 |
JP2004069670A (en) | 2004-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2156862T3 (en) | METHOD FOR SELECTING MORPHOGENIC PROTEINS. | |
Reinhard et al. | VASP interaction with vinculin: a recurring theme of interactions with proline‐rich motifs | |
Franke et al. | Differences of expression of cytoskeletal proteins in cultured rat hepatocytes and hepatoma cells | |
Nebgen et al. | Identification of the chondrogenic-inducing activity from bovine dentin (bCIA) as a low-molecular-mass amelogenin polypeptide | |
TIMPL et al. | The aminopropeptide of collagen | |
Bowden et al. | Expression and modification of keratins during terminal differentiation of mammalian epidermis | |
Takeichi et al. | Identification of a gene family of cadherin cell adhesion molecules | |
ATE272109T1 (en) | RECOMBINANT COLLAGENASE TYPE I FROM CLOSTRIDIUM HISTOLYTICUM AND THE USE THEREOF FOR ISOLATING CELLS AND CELL COMPOUNDS | |
PT670898E (en) | POLYEPEPTIDES OF MULTIPLE MOLECULES OF INTERLEUCIN-3 (IL-3) | |
ATE352617T1 (en) | SOLUBLE POLYPEPTIDE FRACTIONS OF LAG-3 PROTEIN; METHOD OF PRODUCTION; THERAPEUTIC COMPOSITION; ANTIDIOTYPICAL ANTIBODIES | |
Schaffeld et al. | Vimentin and desmin of a cartilaginous fish, the shark Scyliorhinus stellaris: sequence, expression patterns and in vitro assembly | |
Cossart | Actin-based bacterial motility: towards a definition of the minimal requirements | |
AU6444190A (en) | A polypeptide | |
US9074175B2 (en) | Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof | |
US20080145884A1 (en) | Sfrp and peptide motifs that interact with sfrp and methods of their use | |
BR9407512A (en) | Nucleic acid sequence defective recombinant virus vector, notably virale, pharmaceutical composition and use of a nucleic acid sequence | |
KR960701899A (en) | Protein Complexes Having Factor VIII: C Activity and Their Preparation | |
Mintzas et al. | Translation of the mRNAs coding for the major hemolymph proteins of Ceratitis capitata in cell-free system: comparison of the translatable mRNA levels to the respective biosynthetic levels of the proteins in the fat body during development | |
CA2345287A1 (en) | Tgf-beta superfamily mutant members, including morphogenic proteins | |
Schaffeld et al. | Type II keratin cDNAs from the rainbow trout: implications for keratin evolution | |
Oka et al. | Inductive Influences of Epimorphin on Endothelial Cellsin Vitro | |
Teodoro et al. | Increase of interstitial collagen in the mouse endometrium during decidualization | |
Robinson | Comparative biochemical analysis of sea urchin peristome and rat tail tendon collagen | |
AU2002241859A1 (en) | sFRP and peptide motifs that interact with sFRP and methods of their use | |
US5821223A (en) | Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 601129 Country of ref document: ES |